NSE: COLPAL | BSE: 500830

Expensive Performer

Download real time

2156.90 -8.00 (-0.37%)

209.0K NSE+BSE Volume

NSE 22 May, 2026 3:31 PM (IST)

58,664.6

Market Cap

High in industry

Beta 1Year

Low volatility

Rapid Results

Q4FY26 & FY26 Result Announced for Colgate-Palmolive (India) Ltd. See details

Colgate-Palmolive (India) Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COLPAL, BSE:500830 Colgate-Palmolive (India) Ltd.

Search Inside the pdf :

Colgate-Palmolive (India) Ltd.

30 Jan 2026

2156.90

-0.37%

Soft volume delivery; expect a better display in FY27

Buy: Colgate-Palmolive (India) ...

Target

Motilal Oswal

Colgate’s (CLGT) delivered 2% YoY revenue growth to INR14.9b (est. INR14.9b) in 3QFY26, clocking positive growth after three consecutive quarters of decline.

Colgate-Palmolive (India) Ltd. is trading above its 150 day SMA of 2120.4

Colgate-Palmolive (India) Ltd.

06 Nov 2025

2156.90

-0.37%

COLGATE PALMOLIVE INDIA LTD

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Geojit BNP Paribas

Colgate's revenue fell during the quarter due to temporary distribution disruptions following the revision in GST rates on oral care portfolio. However, its business fundamentals remained strong with continued brand investments and steady demand in premium segments. The company's strategic focus on innovation, product diversification and rural penetration is expected to aid recovery in the second half of FY26. Ongoing cost optimization under the funding the growth' program, coupled with innovation-led launches in oral and personal care should...

Number of FII/FPI investors decreased from 750 to 741 in Mar 2026 qtr

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2156.90

-0.37%

Sales decline amid GST-led distribution disruption.

Accumulate: Colgate-Palmolive (India) ...

Target

Deven Choksey

Management expects a gradual demand recovery in H2FY26E, supported by improving macro indicators and internal execution initiatives.

Colgate-Palmolive (India) Ltd. is trading below its 200 day SMA of 2163.0

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2156.90

-0.37%

Result Update:Colgate-Palmoliv

Buy: Colgate-Palmolive (India) ...

Target

Axis Direct

With an upside of 12% from the CMP, we maintain our BUY rating on the stock

Colgate-Palmolive (India) Ltd. is trading below its 200 day SMA of 2163.0

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2156.90

-0.37%

Same story. SELL

Sell: Colgate-Palmolive (India) ...

ICICI Securities Limited

Colgate’s Q2FY26 result reaffirms that business remains structurally fatigued, with no visible triggers for a turnaround. Revenue declined 6.2% YoY, implying a 7-8% volume decline amid GST-led destocking and continued competitive intensity.

Colgate-Palmolive (I.. has an average target of 2431.43 from 7 brokers.

Colgate-Palmolive (India) Ltd.

23 Oct 2025, 12:00AM

2156.90

-0.37%

Muted 2Q print; watchful for growth recovery ahead

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Motilal Oswal

Colgate’s (CLGT) 2QFY26 performance remained weak as its revenue fell 6% YoY to INR15.2b (in line) on a high base of 10% growth and due to the impact of GST-led transition (trade disruptions).

Number of FII/FPI investors decreased from 750 to 741 in Mar 2026 qtr

Colgate-Palmolive (India) Ltd.

23 Oct 2025, 12:00AM

2156.90

-0.37%

Colgate Palmolive (CLGT IN) Q2FY26 Result Update Competitive...

Hold: Colgate-Palmolive (India) ...

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 750 to 741 in Mar 2026 qtr

Colgate-Palmolive (India) Ltd.

05 Sep 2025

2156.90

-0.37%

Company Update:Colgate-Palmoliv

Buy: Colgate-Palmolive (India) ...

Target

Axis Direct

Maintain BUY ratings on with a revised TP at Rs 2,780.

Number of FII/FPI investors decreased from 750 to 741 in Mar 2026 qtr

Colgate-Palmolive (India) Ltd.

25 Jul 2025

2156.90

-0.37%

Urban demand impacted growth; a gradual recovery is expected from H2FY26E

Accumulate: Colgate-Palmolive (India) ...

Deven Choksey

Colgate Palmolive India’s Q1FY26 performance stood below our expectations across the board, reflecting persistent headwinds from tough operating conditions led by muted urban demand and elevated competition intensity.